$FLGT
Fulgent Genetics, Inc.

2020 Q1 Form 10-Q Financial Statement

#000156459020021956 Filed on May 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $7.753M $5.370M
YoY Change 44.38% 15.41%
Cost Of Revenue $4.057M $2.968M
YoY Change 36.69% 7.07%
Gross Profit $3.696M $2.402M
YoY Change 53.87% 27.7%
Gross Profit Margin 47.67% 44.73%
Selling, General & Admin $3.632M $2.801M
YoY Change 29.67% 7.03%
% of Gross Profit 98.27% 116.61%
Research & Development $1.978M $1.424M
YoY Change 38.9% -2.33%
% of Gross Profit 53.52% 59.28%
Depreciation & Amortization $569.0K $535.0K
YoY Change 6.36% 3.68%
% of Gross Profit 15.4% 22.27%
Operating Expenses $5.610M $4.225M
YoY Change 32.78% 3.68%
Operating Profit -$1.914M -$1.823M
YoY Change 4.99% -16.91%
Interest Expense $200.0K $200.0K
YoY Change 0.0% 100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.673M -$1.616M
YoY Change 3.53% -23.01%
Income Tax $34.00K $13.00K
% Of Pretax Income
Net Earnings -$1.956M -$1.908M
YoY Change 2.52% -0.1%
Net Earnings / Revenue -25.23% -35.53%
Basic Earnings Per Share
Diluted Earnings Per Share -$92.59K -$104.4K
COMMON SHARES
Basic Shares Outstanding 21.57M
Diluted Shares Outstanding 21.57M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.30M $29.40M
YoY Change -7.14% 3.16%
Cash & Equivalents $9.302M $5.288M
Short-Term Investments $18.00M $24.10M
Other Short-Term Assets $2.700M $1.400M
YoY Change 92.86% 40.0%
Inventory
Prepaid Expenses $1.211M $987.0K
Receivables $6.500M $4.600M
Other Receivables $32.00K $17.00K
Total Short-Term Assets $37.00M $36.30M
YoY Change 1.93% 0.55%
LONG-TERM ASSETS
Property, Plant & Equipment $8.200M $8.900M
YoY Change -7.87% 28.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $43.90M $10.20M
YoY Change 330.39% -15.0%
Other Assets $200.0K $231.0K
YoY Change -13.42% -53.8%
Total Long-Term Assets $52.30M $19.35M
YoY Change 170.26% 0.27%
TOTAL ASSETS
Total Short-Term Assets $37.00M $36.30M
Total Long-Term Assets $52.30M $19.35M
Total Assets $89.30M $55.65M
YoY Change 60.46% 0.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.900M $1.456M
YoY Change 99.18% 12.0%
Accrued Expenses $2.500M $1.354M
YoY Change 84.64% 23.09%
Deferred Revenue $444.0K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.800M $3.200M
YoY Change 81.25% 33.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.100M $2.500M
YoY Change -16.0%
Total Long-Term Liabilities $2.100M $2.500M
YoY Change -16.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.800M $3.200M
Total Long-Term Liabilities $2.100M $2.500M
Total Liabilities $8.000M $5.700M
YoY Change 40.35% 136.02%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $81.37M $49.96M
YoY Change
Total Liabilities & Shareholders Equity $89.30M $55.70M
YoY Change 60.32% 0.47%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$1.956M -$1.908M
YoY Change 2.52% -0.1%
Depreciation, Depletion And Amortization $569.0K $535.0K
YoY Change 6.36% 3.68%
Cash From Operating Activities $1.366M $1.055M
YoY Change 29.48% -181.72%
INVESTING ACTIVITIES
Capital Expenditures $796.0K $134.0K
YoY Change 494.03% -87.99%
Acquisitions
YoY Change
Other Investing Activities -$3.100M -$2.400M
YoY Change 29.17% -300.0%
Cash From Investing Activities -$3.862M -$2.500M
YoY Change 54.48% -5001.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $176.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -164.0K 4.000K
YoY Change -4200.0% 100.0%
NET CHANGE
Cash From Operating Activities 1.366M 1.055M
Cash From Investing Activities -3.862M -2.500M
Cash From Financing Activities -164.0K 4.000K
Net Change In Cash -2.663M -1.448M
YoY Change 83.91% 16.96%
FREE CASH FLOW
Cash From Operating Activities $1.366M $1.055M
Capital Expenditures $796.0K $134.0K
Free Cash Flow $570.0K $921.0K
YoY Change -38.11% -138.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2633000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
251000
CY2019Q4 us-gaap Assets
Assets
88756000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1581000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1333000
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
24000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2256000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
924000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
46000
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
56000
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
444000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
431000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-339000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
924000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
583000
CY2020Q1 us-gaap Depreciation
Depreciation
569000
CY2019Q1 us-gaap Depreciation
Depreciation
535000
CY2020Q1 flgt Noncash Lease Expense
NoncashLeaseExpense
108000
CY2019Q1 flgt Noncash Lease Expense
NoncashLeaseExpense
100000
CY2020Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
105000
CY2019Q1 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
37000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
51152000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
583000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
130000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
49961000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1448000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11965000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6736000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9302000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5288000
CY2020Q1 flgt Non Cash Or Part Non Cash Investment In Marketable Securities
NonCashOrPartNonCashInvestmentInMarketableSecurities
500000
CY2020Q1 flgt Noncash Or Part Noncash Public Offering Costs Included In Accounts Payable
NoncashOrPartNoncashPublicOfferingCostsIncludedInAccountsPayable
1000
CY2020Q1 flgt Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-101000
CY2019Q1 flgt Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-93000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1366000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1055000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
121000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
42000
CY2019Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
28000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-104000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1414000
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
924000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-64000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1907000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
79000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
34000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
268000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-7000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
796000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
134000
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
3600000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
130000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2663000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
61532000
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
61322000
CY2020Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3943000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting periods. These estimates, judgments and assumptions are based on historical data and experience available at the date of the accompanying condensed consolidated financial statements, as well as various other factors management believes to be reasonable under the circumstances, including but not limited to the potential impacts arising from the recent global pandemic related to the novel coronavirus (&#8220;COVID-19&#8221;). As the extent and duration of the impacts from COVID-19 remain unclear, the Company&#8217;s estimates and assumptions may evolve as conditions change. Actual results could differ significantly from these estimates. Actual results could differ from these estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an on-going basis, management evaluates its estimates, primarily those related to: (i) revenue recognition criteria, (ii) accounts receivable and allowances for doubtful accounts, (iii) the useful lives of fixed assets, (iv) estimates of tax liabilities and (v) equity method investments.</p>
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
33000
CY2019Q1 us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
159000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
369000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
58124000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
159000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
32000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
58251000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
6399000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
85000
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
242000
CY2020Q1 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
369000
CY2019 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
32000
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2020Q1 flgt Fair Value Assets Transfers Between Levels Amount
FairValueAssetsTransfersBetweenLevelsAmount
0
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13964000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0
CY2020Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14257000
CY2020Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3000000
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8559000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7990000
CY2020Q1 flgt Reagents And Supplies Current
ReagentsAndSuppliesCurrent
1531000
CY2019Q4 flgt Reagents And Supplies Current
ReagentsAndSuppliesCurrent
277000
CY2020Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
150000
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
150000
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1211000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1288000
CY2020Q1 us-gaap Prepaid Taxes
PrepaidTaxes
46000
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
46000
CY2020Q1 flgt Marketable Securities Interest Receivable Current
MarketableSecuritiesInterestReceivableCurrent
354000
CY2019Q4 flgt Marketable Securities Interest Receivable Current
MarketableSecuritiesInterestReceivableCurrent
478000
CY2020Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
32000
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
16000
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q1 flgt Operating Leases Term Of Expiration
OperatingLeasesTermOfExpiration
2023-08
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
384000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2600000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
149000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
146000
CY2020Q1 flgt Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
163000
CY2019Q1 flgt Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
134000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y4M24D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0625
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
433000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
591000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
597000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
567000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
330000
CY2020Q1 flgt Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
317000
CY2020Q1 flgt Lessee Operating Lease Liability Payments Due Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueThereafter
215000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3050000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
476000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2574000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
924000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
583000
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.02
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.01
CY2020Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30
CY2019Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30

Files In Submission

Name View Source Status
0001564590-20-021956-index-headers.html Edgar Link pending
0001564590-20-021956-index.html Edgar Link pending
0001564590-20-021956.txt Edgar Link pending
0001564590-20-021956-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
flgt-10q_20200331.htm Edgar Link pending
flgt-20200331.xml Edgar Link completed
flgt-20200331.xsd Edgar Link pending
flgt-20200331_cal.xml Edgar Link unprocessable
flgt-20200331_def.xml Edgar Link unprocessable
flgt-20200331_lab.xml Edgar Link unprocessable
flgt-20200331_pre.xml Edgar Link unprocessable
flgt-ex311_6.htm Edgar Link pending
flgt-ex312_7.htm Edgar Link pending
flgt-ex321_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending